logo-loader

Propanc Biopharma, Inc.

Receive alerts
Market:
OTCQB
Market Cap:
$330.11 k
Price
0.25 USD
Change
-6.78%
52 weeks high
28.50
52 weeks low
0.06

In brief

Propanc Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. Together with our scientific and oncology consultants, we have developed a novel therapeutic approach based on 100 years of the scientific study of enzyme use. Our leading products not only treat metastatic cancer but reduce recurrence.